COMP <GO>
OSCR vs HSIC // ALTMAN Z-SCORE & DEBT/EQUITY
Oscar Health Inc. (NYSE) VS. Henry Schein Inc. (NASDAQ) • 15-METRIC TALLY: OSCR 3
— HSIC 8
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: HSIC
LAST: $31.00 (+2.07%) • MKT CAP: $9.37B
balance-sheet
0.45
LAST: $86.62 (+2.05%) • MKT CAP: $9.46B
balance-sheet
2.81
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OSCR VS. HSIC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OSCR | HSIC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 31.10% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 11.20% | -46.20 | HSIC | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 9.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 11.51% | 1.23% | +10.28 | OSCR | /fcf-yield <GO> |
| Operating Margin | -60.00% | 5.00% | -65.00 | HSIC | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 3.20% | -63.20 | HSIC | /net-margins <GO> |
| Revenue Growth (YoY) | 39.00% | 4.00% | +35.00 | OSCR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 0.45 | 2.81 | -2.36 | HSIC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | HSIC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.9 | 47.5 | -5.60 | HSIC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.97 | 0.89 | +0.08 | OSCR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.0x | 21.4x | +1.60 | HSIC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.37B | $9.46B | -$86.0M | HSIC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OSCR REV | HSIC REV | OSCR GROSS % | HSIC GROSS % | OSCR FCF | HSIC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $28.6M | $13.18B | — | 31.1% | $1.09B | $118.7M |
| FY 2024 | $20.6M | $12.67B | — | 31.7% | $977.3M | $277.7M |
| FY 2023 | $21.4M | $12.34B | — | — | -$273.1M | -$55.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OSCR // BETA 0.97
HSIC // BETA 0.89